Chemical ID
BRUCEANTIN
Ubiquitous
No
Dosage | Reference |
---|---|
LD50=1.9-2.6 (ivn mus) | Merck 11th Edition |
Activity | Dosage | Reference |
---|---|---|
Amebicide | IC50=0.035 uM | Duke, 1992 * |
Antibacterial | IC9=12.5 ug/ml | Duke, 1992 * |
Antifeedant | not available | Duke, 1992 * |
Antigiardial | IC50=1.2 uM | Duke, 1992 * |
Antileukemic | not available | Merck 11th Edition |
Antimalarial | IC50=0.8 ng/ml | Duke, 1992 * |
Antimelanomic | ED50=0.001 ug/ml | J. Ethnopharmacology, 32: 117. |
Antisarcomic | ED50=0.0014 ug/ml | J. Ethnopharmacology, 32: 117. |
Antiseptic | IC9=12.5 ug/ml | Duke, 1992 * |
Antitubercular | IC9=12.5 ug/ml | Duke, 1992 * |
Antitumor (Breast) | ED50=0.003 ug/ml | Cordell, G.A., Beecher, C.W.W., and Pezzuto, J.M. Can ethnopharmacology contribute to the development of new anticancer drugs? Journal of Ethnopharmacology, 32: 117-133, 1991. |
Antitumor (Colon) | ED50=0.0074 ug/ml | Cordell, G.A., Beecher, C.W.W., and Pezzuto, J.M. Can ethnopharmacology contribute to the development of new anticancer drugs? Journal of Ethnopharmacology, 32: 117-133, 1991. |
Cytotoxic | 1 ppb | Duke, 1992 * |
Cytotoxic | (KB) IC50=0.015 uM | Duke, 1992 * |
Mycobactericide | IC9=12.5 ug/ml | Duke, 1992 * |
Pesticide | not available | Duke, 1992 * |
Plasmodicide | IC50=0.0015 uM | Duke, 1992 * |
Pyrogenic | 5.5 mg/sq m body, ivn hmn | Garnick, M. B., Blum, R. H., Canellos, G. P., Mayer, R. J., Parker, L., Skarin, A. T., Li, F. P., Henderson, I. C., Frei III, E. 1979. Phase I Trial of Bruceantin. Cancer Treat Rep, 63: 1929-1932. |
Trypanocide | IC50=0.0015 uM | Duke, 1992 * |